abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to an agent exhibiting nootropic action. The declared agent contains calcium chloride, sodium chloride, ferric sulphate (II), zinc sulphate, chromium chloride (III) and potassium bromide in certain proportions. n EFFECT: invention provides normalisation of the CNS function ensured by nootropic action. n 1 tbl, 4 ex |